Product Information
SYNJARDY XR 25-1,000 MG TABLET is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $11.1935 per EA under NDC 00597029588. Its NADAC has been published 453 times since Dec 20, 2017.
FDA first approved this application on Dec 9, 2016.
Strength
25; 1000 mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597029588
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA208658FDA Approved
12/9/2016
On Market Since
12/10/2016
Pharmacological Classes
Price Statistics
The NADAC for SYNJARDY XR 25-1,000 MG TABLET has been published 453 times since Dec 20, 2017, and over the history we have for it it has declined 19.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.1935 per EA |
|---|---|
| All-time high | $20.1486 (Dec 31, 2025) |
| All-time low | $11.1883 (May 20, 2026) |
| 52-week high | $20.1486 |
| 52-week low | $11.1883 |
| Median price | $17.5189 |
| Average price | $17.2327 |
| Largest weekly change | -44.4% (Jan 7, 2026) |
| Weeks tracked | 453 |
| Tracking since | Dec 20, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SYNJARDY XR 25-1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SYNJARDY XR 25-1,000 MG TABLET, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $11.1935 per EA (NDC 00597029588), effective Aug 19, 2026.
How has the price of SYNJARDY XR 25-1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for SYNJARDY XR 25-1,000 MG TABLET has declined 19.6%. It has been tracked across 453 weekly CMS publications since Dec 20, 2017.
What are the highest and lowest recorded NADAC prices for SYNJARDY XR 25-1,000 MG TABLET?
Since Dec 20, 2017, the NADAC for SYNJARDY XR 25-1,000 MG TABLET has ranged from a low of $11.1883 (May 20, 2026) to a high of $20.1486 (Dec 31, 2025), with a median of $17.5189 per EA.
Are there cheaper alternatives to SYNJARDY XR 25-1,000 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SYNJARDY XR 25-1,000 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SYNJARDY XR 25-1,000 MG TABLET?
SYNJARDY XR 25-1,000 MG TABLET (NDC 00597029588) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.